BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Toapanta FR, Bernal PJ, Kotloff KL, Levine MM, Sztein MB. T cell mediated immunity induced by the live-attenuated Shigella flexneri 2a vaccine candidate CVD 1208S in humans. J Transl Med 2018;16:61. [PMID: 29534721 DOI: 10.1186/s12967-018-1439-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Gazi MA, Das S, Mahfuz M, Hasan MM, Hossain MS, Fahim SM, Alam MA, Noor Z, Gilchrist CA, Petri WA, Rahman MM, Mazumder RN, Haque R, Sarker SA, Ahmed T. Screening for coeliac disease in children and adults living in a slum of Dhaka, Bangladesh. BMJ Open Gastroenterol 2019;6:e000294. [PMID: 31139429 DOI: 10.1136/bmjgast-2019-000294] [Reference Citation Analysis]
2 Visvabharathy L, Hanson B, Orban Z, Lim PH, Palacio N, Jain R, Liotta EM, Penaloza-MacMaster P, Koralnik IJ. Neuro-COVID long-haulers exhibit broad dysfunction in T cell memory generation and responses to vaccination. medRxiv 2021:2021. [PMID: 34401886 DOI: 10.1101/2021.08.08.21261763] [Reference Citation Analysis]
3 Ndungo E, Randall A, Hazen TH, Kania DA, Trappl-Kimmons K, Liang X, Barry EM, Kotloff KL, Chakraborty S, Mani S, Rasko DA, Pasetti MF. A Novel Shigella Proteome Microarray Discriminates Targets of Human Antibody Reactivity following Oral Vaccination and Experimental Challenge. mSphere 2018;3:e00260-18. [PMID: 30068560 DOI: 10.1128/mSphere.00260-18] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
4 Ranjbar R, Farahani A. Shigella: Antibiotic-Resistance Mechanisms And New Horizons For Treatment. Infect Drug Resist 2019;12:3137-67. [PMID: 31632102 DOI: 10.2147/IDR.S219755] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
5 Chapartegui-González I, Bowser S, Torres AG, Khakhum N. Recent Progress in Shigella and Burkholderia pseudomallei Vaccines. Pathogens 2021;10:1353. [PMID: 34832508 DOI: 10.3390/pathogens10111353] [Reference Citation Analysis]
6 Mani S, Toapanta FR, McArthur MA, Qadri F, Svennerholm AM, Devriendt B, Phalipon A, Cohen D, Sztein MB. Role of antigen specific T and B cells in systemic and mucosal immune responses in ETEC and Shigella infections, and their potential to serve as correlates of protection in vaccine development. Vaccine 2019;37:4787-93. [PMID: 31230883 DOI: 10.1016/j.vaccine.2019.03.040] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
7 Shahnaij M, Latif HA, Azmi IJ, Amin MB, Luna SJ, Islam MA, Talukder KA. Characterization of a serologically atypical Shigella flexneri Z isolated from diarrheal patients in Bangladesh and a proposed serological scheme for Shigella flexneri. PLoS One 2018;13:e0202704. [PMID: 30142163 DOI: 10.1371/journal.pone.0202704] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
8 Bazhenova A, Gao F, Bolgiano B, Harding SE. Glycoconjugate vaccines against Salmonella enterica serovars and Shigella species: existing and emerging methods for their analysis. Biophys Rev 2021;:1-26. [PMID: 33868505 DOI: 10.1007/s12551-021-00791-z] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]